These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1912773)

  • 21. Audit of neonatal screening programme for phenylketonuria and congenital hypothyroidism.
    Simpson N; Randall R; Lenton S; Walker S
    Arch Dis Child Fetal Neonatal Ed; 1997 Nov; 77(3):F228-34. PubMed ID: 9462195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coverage of neonatal screening: failure of coverage or failure of information system.
    Ades AE; Walker J; Jones R; Smith I
    Arch Dis Child; 2001 Jun; 84(6):476-9. PubMed ID: 11369561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of effectiveness of screening for phenylketonuria in the United States, United Kingdom and Ireland.
    Starfield B; Holtzman NA
    N Engl J Med; 1975 Jul; 293(3):118-21. PubMed ID: 1134518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a nation-wide neonatal metabolic screening programme in Sweden 1965-1979.
    Alm J; Larsson A
    Acta Paediatr Scand; 1981 Sep; 70(5):601-7. PubMed ID: 7324907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].
    Verkerk PH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2302-5. PubMed ID: 7501062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for phenylketonuria and congenital hypothyroidism in 5.8 million neonates in China].
    Gu XF; Wang ZG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Mar; 38(2):99-102. PubMed ID: 15061917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylketonuria in South Africa. A report on the status quo.
    Hitzeroth HW; Niehaus CE; Brill DC
    S Afr Med J; 1995 Jan; 85(1):33-6. PubMed ID: 7784915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylketonuria: contemporary screening and diagnosis.
    Mabry CC
    Ann Clin Lab Sci; 1990; 20(6):393-7. PubMed ID: 2073089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylketonuria: management in primary care.
    Wall A; MacDonald A; Asplin D; Weetch E
    J Fam Health Care; 2006; 16(3):68-9. PubMed ID: 16886728
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program.
    Botler J; Camacho LA; Cruz MM
    Cad Saude Publica; 2012 Sep; 28(9):1623-31. PubMed ID: 23033178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for cystic fibrosis: the practice and the debate.
    Bonham JR; Downing M; Dalton A
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S42-5. PubMed ID: 14618394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of phenylketonuria in Israel.
    Merrick J; Schwarz G; Sela BA
    Isr Med Assoc J; 2000 Oct; 2(10):801-2. PubMed ID: 11344743
    [No Abstract]   [Full Text] [Related]  

  • 33. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
    González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
    Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.
    Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS
    Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylketonuria screening with a fluorometric microplate assay.
    Lubenow N; Diepenbrock F; Schickling H; Bock D; Heckler R; Sander J
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):525-8. PubMed ID: 7981333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the phenylalanine:tyrosine ratio to test newborns for phenylketonuria in a large public health screening programme.
    Eastman JW; Sherwin JE; Wong R; Liao CL; Currier RJ; Lorey F; Cunningham G
    J Med Screen; 2000; 7(3):131-5. PubMed ID: 11126161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. United Arab Emirates National Newborn Screening Programme: an evaluation 1998-2000.
    al-Hosani H; Salah M; Saade D; Osman H; al-Zahid J
    East Mediterr Health J; 2003 May; 9(3):324-32. PubMed ID: 15751925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
    Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
    Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What disorders suspect following an increase of phenylalanine on newborn screening?].
    Michel MA; Raucourt E; Bednarek N; Garnotel R
    Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CASE-FINDING IN PHENYLKETONURIA. I. REPORT OF A SURVEY BY THE COLLEGE OF GENERAL PRACTICE OF CANADA.
    PARTINGTON MW; ANDERSON RM
    Can Med Assoc J; 1964 Jun; 90(23):1312-4. PubMed ID: 14155126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.